We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Effective Surgical Treatment for Sleep Apnea

By HospiMedica staff writers
Posted on 17 Sep 2007
An innovative procedure known as Genial Bone Advancement Trephine (GBAT) treatment is being used to treat obstructive sleep apnea (OSA) syndrome in patients in whom traditional treatments have proven to be ineffective. More...


Researchers at Thomas Jefferson University (Philadelphia, PA, USA) are performing GBAT as an option for patients when medications or a continuous positive airway pressure (C-PAP) device are insufficient.

The GBAT system allows genioglossus advancement (GGA) of the tongue via a guided trephine system. The procedure involves moving a small portion of the lower jaw known as the genial tubercle, which attaches to the tongue. When this tubercle is moved forward, the tongue is pulled away from the pharynx, increasing the airway space. The procedure is often employed as an adjunct to more conventional surgery and can be very effective at treating OSA.

At the end of the GBAT procedure, the genial tubercle is fastened using a small titanium plate to the outside of the lower jaw. The surgeon works from within the oral cavity, avoiding the need to make any external incisions and avoiding any cosmetic changes. The procedure is usually carried out in conjunction with uvulopalatopharyngoplasty (UPPP) surgery, used to remove excess tissue at the back of the throat (tonsils, uvula, and part of the soft palate). The patient may experience soreness but will not have any change in dental occlusion. The recovery period is usually about two weeks, and three to six months after the procedure, follow-up sleep tests are performed.

"Even immediately after the procedure patients have an easier time breathing,” said Maurits Boon, M.D., a clinical instructor in otolaryngology-head and neck surgery at Thomas Jefferson. "We have also observed that in a select group of patients hypertension drops off.”


Related Links:
Thomas Jefferson University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.